|Last Price$62.19||Day Change (%)-5.21%|
|Open Price$62.89||Day Change ($)-3.42|
|Day Range61.38–62.89||52-Week Range57.00–77.92|
As of Mon 6/27/2016 5:02:00 PM | USD
IHS and Markit Announce Exchange Offer and Consent Solicitation for IHS Notes
Fitch Affirms WhiteHorse IX , Ltd.; Outlook Stable
Christopher & Banks Corporation Reports First Quarter Fiscal 2016 Financial Results
Greif Reports Second Quarter 2016 Results
IHS and Markit Announce Senior Executive Leadership Appointments for IHS Markit
CyrusOne Announces Another Record Lease Signing Quarter Totaling $49 Million in Annualized GAAP Revenue
Nanoco Casts Doubt on Inconclusive Öko Institute Advisory to Extend Cadmium Exemption under the Restriction of Hazardous Substances (RoHS) Directive for TVs, Displays
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.